SGHT Q4 2023 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M-8.7% YoY

Gross Profit

$16M85.2% margin

Operating Income

-$11M-59.3% margin

Net Income

-$11M-57.0% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$167M

Total Liabilities

$46M

Stockholders' Equity

$120M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$21M	-8.7%
Gross Profit	$16M	$17M	-5.4%
Operating Income	-$11M	-$17M	+34.9%
Net Income	-$11M	-$17M	+36.8%

Revenue Segments

Surgical Glaucoma

$17M87%

Dry Eye

$3M13%